| Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2010 Results for June 10, 2010, at 8:30 AM E.T. (Business Wire) NEW YORK----Enzo Biochem, Inc. , will hold a conference call to discuss its fiscal 2010 third quarter results on Thursday, June 10, 2010, at 8:30 AM ET. us.rd.yahoo.com |
Arena Inks a Potential Blockbuster Deal KLLJ Investments submits: In my SA article from May, I discussed the potential value for Lorcaserin in the marketplace. As I stated then, " a partnership before approval can quickly change the game. I fully expect that to happen and once it does, we’ll have insight into how Big Pharma values a First Line Obesity Treatment."Complete Story » seekingalpha.com |
CVS/pharmacy offers flu shots - Video CVS/pharmacy and MinuteClinic Offer “Flu Shots Your Way” At All Locations Nationwide feedproxy.google.com |
Arena's Weight Loss Drug in Trouble Baskin Financial Blog submits: The FDA committee that will be looking over Arena's (ARNA) lorcaserin for weight loss has released its briefing information, and there were some nasty surprises therein. A memo states that the drug did not satisfy the mean efficacy requirements that the FDA has laid down for obesity therapies, and satisfied the categorical efficacy one "by a slim margin". Well, that was known. I said as much back in May of last year, and didn't the Arena fans ever give me an earful about it. What wasn't apparent was the two-year rodent tox. The briefing document raises questions about the number of malignancies that showed up in these rats, and that's not good. The safety profile of any drug in this area has to be very clean, especially if the efficacy is borderline.Complete Story » seekingalpha.com |
Runway, Real Way, NARS Way - Video Videos Showcase How-To-Get The NARS Makeup Looks Straight From NY Fashion Week feedproxy.google.com |